Diversity-oriented synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors.

MLA

Lukens, Amanda K., et al. “Diversity-Oriented Synthesis Probe Targets Plasmodium Falciparum Cytochrome b Ubiquinone Reduction Site and Synergizes with Oxidation Site Inhibitors.” The Journal of Infectious Diseases, vol. 211, no. 7, Apr. 2015, pp. 1097–103. EBSCOhost, https://doi.org/10.1093/infdis/jiu565.

APA

Lukens, A. K., Heidebrecht, R. W., Jr, Mulrooney, C., Beaudoin, J. A., Comer, E., Duvall, J. R., Fitzgerald, M. E., Masi, D., Galinsky, K., Scherer, C. A., Palmer, M., Munoz, B., Foley, M., Schreiber, S. L., Wiegand, R. C., & Wirth, D. F. (2015). Diversity-oriented synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors. The Journal of Infectious Diseases, 211(7), 1097–1103. https://doi.org/10.1093/infdis/jiu565

Chicago

Lukens, Amanda K, Richard W Heidebrecht Jr, Carol Mulrooney, Jennifer A Beaudoin, Eamon Comer, Jeremy R Duvall, Mark E Fitzgerald, et al. 2015. “Diversity-Oriented Synthesis Probe Targets Plasmodium Falciparum Cytochrome b Ubiquinone Reduction Site and Synergizes with Oxidation Site Inhibitors.” The Journal of Infectious Diseases 211 (7): 1097–1103. doi:10.1093/infdis/jiu565.